Home ⟩ Insights

Insights

fda

2 min read • June 1, 2022

DEA Delays Medical Marijuana Clinical Trials Yet Illicit Market Continues To Thrive

3 min read • May 4, 2022

FDA Issues Warning Letters To Companies Illegally Selling Delta-8 THC, Calls It Dangerous To Consumers

5 min read • May 4, 2022

FDA Issues Warning Letters To Companies Illegally Selling CBD And Delta-8 THC Products

4 min read • March 31, 2022

FDA Warns CBD Companies To Stop Claiming Their Products Can Treat COVID-19

2 min read • March 30, 2022

FDA Says Yes To Testing Receptor Life’s Dry Power Inhaled CBD To Treat Social Anxiety Disorder

4 min read • March 25, 2022

Federal Cannabis Legalization: Are The Stars Aligning? Will The Dems And GOP Meet In The Middle?

2 min read • March 14, 2022

Wesana Health One Step Closer To Clinical Trials Of Psilocybin And CBD Based Treatment Of Brain Injury Related MDD

2 min read • March 11, 2022

U.S. Senate Appropriations Committee Directs FDA To Regulate CBD And Study Products On The Market

3 min read • March 8, 2022

Michigan, Where Cannabis Is Legal And Not Legal At The Same Time, Listen Closely

2 min read • March 3, 2022

Why Is President Biden Accepting Cannabis Donations While Banning Cannabis Investments?

3 min read • March 3, 2022

Court Dismisses Canopy’s Cannabis Patent Infringement Lawsuit Against Jazz’s GW Pharma

2 min read • February 22, 2022

Hhemp.co Expands Cannabinoid Lineup With THC-O, CBGa And CBDa Products

Latest Headlines

5 min read • September 2, 2026

Aurora Urges Shareholders to Reject Curaleaf Offer, Citing Cash, Debt and Voting Rights

10 min read • September 2, 2026

Curaleaf Escalates Aurora Takeover Fight, Attacks Dilution, Cash Burn and Six-Year Turnaround

3 min read • September 2, 2026

Colorado Cannabis Market Nears $19 Billion in Lifetime Revenue, New Report Shows

2 min read • September 2, 2026

UK Medical Cannabis Prescriptions Surge 165% to 1.77 Million; 25%+ High-THC Products Gain Share

7 min read • September 2, 2026

Decibel Cannabis Reduces Share Count to 38.5 Million After 15:1 Consolidation

3 min read • September 1, 2026

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

8 min read • September 1, 2026

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

2 min read • September 1, 2026

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.